Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

X5's revenue in 2024 to grow by 24%

1/27/25 X5

Seligdar's revenue in 2024 to grow by 8%

1/27/25 SELG

5Post launches cross-border delivery from China

1/27/25 X5

Lukoil's GCC in Stavropol will be built by the end of 2028 - beginning of 2029

1/24/25 LKOH

Eastern Exchange launches IPO infrastructure

1/24/25 MOEX

TGC-1 generation remained at the same level as last year

1/24/25 TGKA

LSR reported a decline in sales

1/24/25 LSRG

Fesco increased transportation between Vladivostok and China

1/24/25 FESH

Fix Price transferred its business to a Russian JSC

1/24/25 FIXP

T-Bank and Rosbank's RAS profit in 2024 increased by 42%

1/24/25 T